HYPERURICEMIA
Clinical trials for HYPERURICEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERURICEMIA trials appear
Sign up with your email to follow new studies for HYPERURICEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough gout: drug combo targets uric acid after other treatments fail
Disease control OngoingThis study tests a new drug called AR882, taken with a standard gout medication (XOI), in 15 people with severe, uncontrolled gout who have already failed uricase therapy. The goal is to see if the combination can lower uric acid levels and shrink painful uric acid crystal deposi…
Matched conditions: HYPERURICEMIA
Phase: PHASE2 • Sponsor: Arthrosi Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New gout drug shows promise in major trial
Disease control OngoingThis study tests a new medicine called AR882 to see if it can lower uric acid levels in people with gout. About 750 adults with gout will receive either AR882 or a placebo for 12 months. The main goal is to see if AR882 helps more patients reach a safe uric acid level and reduce …
Matched conditions: HYPERURICEMIA
Phase: PHASE3 • Sponsor: Arthrosi Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Email your doctor to beat gout: new trial tests remote care
Disease control OngoingThis study tests whether regular email communication between gout patients and their doctors can help lower uric acid levels more effectively than standard care. 204 adults with confirmed gout will either follow usual care or use a secure messaging system to adjust their medicati…
Matched conditions: HYPERURICEMIA
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Scans may spot gout risk years before first attack
Knowledge-focused OngoingThis study follows 21 people with high uric acid but no gout symptoms for up to 5 years. Researchers use ultrasound and CT scans to look for tiny crystal deposits in joints. The goal is to see if these deposits can predict who will later develop painful gout flares.
Matched conditions: HYPERURICEMIA
Phase: NA • Sponsor: Lille Catholic University • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:09 UTC